Elia Marc — SEC insider filings

SEC reporting owner CIK 1830496. 15 insider filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2020-10-30 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Invivyd, Inc. (IVVD)Chief Executive Officer, Director73 legs · 2,850,000 sh · $12,194,680—6
FRACTYL HEALTH, INC. (GUTS)Director41 leg · 466,666 sh · $6,999,990—5
SQZ Biotechnologies Co (SQZ)Director4——4

Insider filings — Elia Marc

FiledFormIssuerReported transactionsSource
2026-09-014Invivyd, Inc. (IVVD)Grant/award (A): 10,700,000 (derivative) @ $0EDGAR
2026-06-114FRACTYL HEALTH, INC. (GUTS)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2026-05-214Invivyd, Inc. (IVVD)
jointly with M28 Capital Management LP
Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-06-134FRACTYL HEALTH, INC. (GUTS)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2025-05-224Invivyd, Inc. (IVVD)
jointly with M28 Capital Management LP
Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-234Invivyd, Inc. (IVVD)
jointly with M28 Capital Management LP
Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-02-084Fractyl Health, Inc. (GUTS)
jointly with M28 Capital Management LP
Conversion (C): 1,389,451 · Purchase (P): 466,666 @ $15 · Conversion (C): 2,981,763 (derivative)EDGAR
2024-02-054Fractyl Health, Inc. (GUTS)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2023-06-154SQZ Biotechnologies Co (SQZ)Grant/award (A): 39,875 (derivative) @ $0EDGAR
2023-05-254Invivyd, Inc. (IVVD)
jointly with M28 Capital Management LP
Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-08-194Adagio Therapeutics, Inc. (ADGI)
jointly with M28 Capital Management LP
Purchase (P): 1,000,000 @ $4.04 · Purchase (P): 1,265,549 @ $4.31 · Purchase (P): 584,451 @ $4.62EDGAR
2022-06-244Adagio Therapeutics, Inc. (ADGI)
jointly with M28 Capital Management LP
Grant/award (A): 150,000 (derivative) @ $0EDGAR
2022-06-164SQZ Biotechnologies Co (SQZ)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-174SQZ Biotechnologies Co (SQZ)Grant/award (A): 10,500 (derivative) @ $0EDGAR
2020-10-304SQZ Biotechnologies Co (SQZ)Grant/award (A): 7,055 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1830496 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs